2 results
Approved WMOWill not start
The main objective of this trial is to investigate the efficacy of inhaled molgramostim compared to placebo.
Approved WMORecruiting
The primary objective of this study is to evaluate the efficacy of CSL112 on reducing the risk of MACE (CV death, MI, or stroke) from the time of randomization through 90 days in subjects with ACS (diagnosed with STEMI or NSTEMI).